Etiracetam
![]()  | |
![]()  | |
| Clinical data | |
|---|---|
| Routes of administration  | Oral | 
| ATC code | 
  | 
| Legal status | |
| Legal status | 
  | 
| Identifiers | |
IUPAC name 
  | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.111.445 | 
| Chemical and physical data | |
| Formula | C8H14N2O2 | 
| Molar mass | 170.212 g·mol−1 | 
| 3D model (JSmol) | |
| Chirality | Racemic mixture | 
SMILES 
  | |
InChI 
  | |
|   | |
Etiracetam is a chemical compound belonging to the racetam family, which was developed as a nootropic drug. It is racemic; its biologically active enantiomeric form is levetiracetam, now marketed as an antiepileptic drug.[1]
See also
References
- ↑ Sara SJ (1980). "Memory retrieval deficits: alleviation by etiracetam, a nootropic drug". Psychopharmacology. 68 (3): 235–41. doi:10.1007/bf00428109. PMID 6771807. S2CID 23369972.
 
    This article is issued from Wmcloud. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

